{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:03:22Z","timestamp":1793657002883,"version":"4.5.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clnesp.2026.103305","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:56:11Z","timestamp":1777046171000},"page":"103305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Medical nutrition in the glucagon-like peptide-1 (GLP-1) era: Protein strategies, micronutrient monitoring, and lean mass preservation"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3356-7332","authenticated-orcid":false,"given":"Sedat","family":"Arslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clnesp.2026.103305_bib1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clnesp.2026.103305_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103305_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(25)00356-0","article-title":"GLP-1 receptor agonists for obesity: eligibility across 99 countries","volume":"14","author":"Yoo","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.clnesp.2026.103305_bib4","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes Metabol"},{"issue":"4","key":"10.1016\/j.clnesp.2026.103305_bib5","first-page":"339","article-title":"Sarcopenic obesity and weight loss-induced muscle mass loss","volume":"28","author":"Caturano","year":"2025","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnesp.2026.103305_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103464","article-title":"Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis","volume":"88","author":"Chu","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.clnesp.2026.103305_bib7","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/dom.16275","article-title":"Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight","volume":"27","author":"Look","year":"2025","journal-title":"Diabetes Obes Metabol"},{"issue":"Supplement_1","key":"10.1016\/j.clnesp.2026.103305_bib8","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1210\/jendso\/bvab048.030","article-title":"Impact of semaglutide on body composition in adults with overweight or obesity: exploratory analysis of the STEP 1 study","volume":"5","author":"Wilding","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.clnesp.2026.103305_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.obmed.2020.100224","article-title":"Micronutrient status in obese patients: a narrative review","volume":"18","author":"Lapik","year":"2020","journal-title":"Obesity Med"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103305_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40795-020-00336-9","article-title":"Overweight & obese Australian adults and micronutrient deficiency","volume":"6","author":"McKay","year":"2020","journal-title":"BMC Nutr"},{"issue":"7","key":"10.1016\/j.clnesp.2026.103305_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.soard.2025.03.009","article-title":"ASMBS literature review & clinical guidelines on prevention, diagnosis, and treatment of Wernicke's encephalopathy and Wernicke-Korsakoff syndrome","volume":"21","author":"Patterson","year":"2025","journal-title":"Surg Obes Relat Dis"},{"issue":"Suppl 1","key":"10.1016\/j.clnesp.2026.103305_bib12","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142026","volume":"49","author":"Committee","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103305_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajcnut.2025.04.023","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society","volume":"122","author":"Mozaffarian","year":"2025","journal-title":"Am J Clin Nutrition"},{"key":"10.1016\/j.clnesp.2026.103305_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2025.100222","article-title":"Optimizing GLP-1 therapies for obesity and diabetes management","volume":"16","author":"Noronha","year":"2025","journal-title":"Obesity pillars"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103305_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014A scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integrity Peer Rev"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103305_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"issue":"8","key":"10.1016\/j.clnesp.2026.103305_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","article-title":"Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE study group","volume":"14","author":"Bauer","year":"2013","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"10.1016\/j.clnesp.2026.103305_bib18","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.clnu.2022.07.003","article-title":"European guideline on obesity care in patients with gastrointestinal and liver diseases\u2013joint ESPEN\/UEG guideline","volume":"41","author":"Bischoff","year":"2022","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103305_bib19","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ijo.2013.162","article-title":"Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults","volume":"38","author":"Van Can","year":"2014","journal-title":"Int J Obes"},{"issue":"10","key":"10.1016\/j.clnesp.2026.103305_bib20","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1111\/dom.15802","article-title":"Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: a randomized controlled trial","volume":"26","author":"Gabe","year":"2024","journal-title":"Diabetes Obes Metabol"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103305_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.14255","article-title":"Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes","volume":"23","author":"Gibbons","year":"2021","journal-title":"Diabetes Obes Metabol"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103305_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12970-018-0215-1","article-title":"How much protein can the body use in a single meal for muscle-building? Implications for daily protein distribution","volume":"15","author":"Schoenfeld","year":"2018","journal-title":"J Int Soc Sports Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103305_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/gerona\/glu103","article-title":"Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men","volume":"70","author":"Moore","year":"2015","journal-title":"J Gerontol Ser A: Biomed Sci Med Sci"},{"key":"10.1016\/j.clnesp.2026.103305_bib24","unstructured":"Academy of Nutrition and Dietetics Evidence Analysis Library. Adult weight management guideline. Evidence analysis Library. Updated 2022. Accessed [18 March 2026]."},{"key":"10.1016\/j.clnesp.2026.103305_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26","author":"Neeland","year":"2024","journal-title":"Diabetes Obes Metabol"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103305_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ndt\/gfae209","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease in children and adults: a commentary from the European Renal Best Practice (ERBP)","volume":"40","author":"Iatridi","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clnesp.2026.103305_bib27","doi-asserted-by":"crossref","first-page":"86S","DOI":"10.1177\/0884533617691745","article-title":"Protein and calorie requirements associated with the presence of obesity","volume":"32","author":"Dickerson","year":"2017","journal-title":"Nutr Clin Pract"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103305_bib28","first-page":"1","article-title":"Revised sarcopenia consensus: are we missing the preclinical stage? Online comment on","volume":"48","author":"Dupont","year":"2018","journal-title":"Age Ageing"},{"issue":"8","key":"10.1016\/j.clnesp.2026.103305_bib29","doi-asserted-by":"crossref","DOI":"10.1519\/JSC.0000000000003230","article-title":"Resistance training for older adults: position statement from the national strength and conditioning association","volume":"33","author":"Fragala","year":"2019","journal-title":"J Strength Condit Res"},{"key":"10.1016\/j.clnesp.2026.103305_bib30","series-title":"Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise","author":"Garber","year":"2011"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103305_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12970-017-0177-8","article-title":"International society of sports nutrition position stand: protein and exercise","volume":"14","author":"J\u00e4ger","year":"2017","journal-title":"J Int Soc Sports Nutr"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726004018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726004018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:32:54Z","timestamp":1779413574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457726004018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"alternative-id":["S2405457726004018"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103305","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical nutrition in the glucagon-like peptide-1 (GLP-1) era: Protein strategies, micronutrient monitoring, and lean mass preservation","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103305"}}